Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
Background Predicting metastasis in melanoma patients is important for disease management and could help to identify those who might benefit from adjuvant treatment. The aim of this study was to investigate whether the tumor microenvironment-derived protein S100A8/A9 qualifies as prognostic marker f...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
5 December 2019
|
| In: |
Journal for ImmunoTherapy of Cancer
Year: 2019, Jahrgang: 7, Heft: 1 |
| ISSN: | 2051-1426 |
| DOI: | 10.1186/s40425-019-0828-1 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s40425-019-0828-1 Verlag, lizenzpflichtig, Volltext: https://jitc.bmj.com/content/7/1/343 
|
| Verfasserangaben: | Nikolaus B. Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis, Valerie Schuermans, Charlotte Kemper, Coretta Kehrel, Anne Funder, Ramtin Lichtenberger, Antje Sucker, Esther Herpel, Tim Holland-Letz, Dirk Schadendorf, Claus Garbe, Viktor Umansky, Jochen Utikal, and Christoffer Gebhardt |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1698224451 | ||
| 003 | DE-627 | ||
| 005 | 20231110122923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200514s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40425-019-0828-1 |2 doi | |
| 035 | |a (DE-627)1698224451 | ||
| 035 | |a (DE-599)KXP1698224451 | ||
| 035 | |a (OCoLC)1341323503 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wagner, Nikolaus B. |d 1987- |e VerfasserIn |0 (DE-588)1111673799 |0 (DE-627)865849749 |0 (DE-576)476241898 |4 aut | |
| 245 | 1 | 0 | |a Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies |c Nikolaus B. Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis, Valerie Schuermans, Charlotte Kemper, Coretta Kehrel, Anne Funder, Ramtin Lichtenberger, Antje Sucker, Esther Herpel, Tim Holland-Letz, Dirk Schadendorf, Claus Garbe, Viktor Umansky, Jochen Utikal, and Christoffer Gebhardt |
| 264 | 1 | |c 5 December 2019 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.05.2020 | ||
| 520 | |a Background Predicting metastasis in melanoma patients is important for disease management and could help to identify those who might benefit from adjuvant treatment. The aim of this study was to investigate whether the tumor microenvironment-derived protein S100A8/A9 qualifies as prognostic marker for melanoma patients, also in the setting of immunotherapy. - Methods S100A8/A9 gene and protein expression were analyzed on melanocytic nevi, primary melanomas and metastases using a cDNA library and three independent tissue-microarrays (TMA). Serum levels of S100A8/A9 were measured using a specific ELISA in two independent cohorts of 354 stage III and stage IV melanoma patients as well as in two independent cohorts of patients treated with the PD-1 antibody pembrolizumab. - Results cDNA analysis revealed an upregulation of S100A8 and S100A9 gene expression in melanoma metastases compared to primary melanomas. Significantly higher numbers of infiltrating S100A8/A9 positive cells were found in tissue samples of metastasizing primary melanomas compared to non-metastasizing melanomas (P < .0001) and in melanomas of short-term survivors compared to long-term survivors (P < .0001). Serum S100A8/A9 levels > 5.5 mg/l were associated with impaired overall survival in two independent cohorts (both P < .0001). Importantly, patients with serum elevated S100A8/A9 treated with pembrolizumab showed significantly impaired survival compared to patients with lower S100A8/A9 levels (cohort 1: P = .0051; cohort 2: P < .0001). - Conclusions The tumor microenvironment-associated protein S100A8/A9 serves as a novel prognostic marker for metastasis and survival of metastatic melanoma patients and predicts response to immunotherapy with pembrolizumab. These data underscore the significance of tumor microenvironment-derived factors as suitable biomarkers for melanoma. | ||
| 650 | 4 | |a Biomarker | |
| 650 | 4 | |a Melanoma | |
| 650 | 4 | |a Metastasis | |
| 650 | 4 | |a PD-1 | |
| 650 | 4 | |a S100 proteins | |
| 650 | 4 | |a S100A8/A9 | |
| 650 | 4 | |a Serum | |
| 700 | 1 | |a Weide, Benjamin Matthias |d 1974- |e VerfasserIn |0 (DE-588)1060768100 |0 (DE-627)800996631 |0 (DE-576)18464223X |4 aut | |
| 700 | 1 | |a Gries, Mirko |d 1985- |e VerfasserIn |0 (DE-588)1229655727 |0 (DE-627)1751726452 |4 aut | |
| 700 | 1 | |a Reith, Maike |e VerfasserIn |0 (DE-588)1078455074 |0 (DE-627)838735924 |0 (DE-576)451515218 |4 aut | |
| 700 | 1 | |a Tarnanidis, Kathrin |e VerfasserIn |0 (DE-588)1080316736 |0 (DE-627)84420398X |0 (DE-576)453479324 |4 aut | |
| 700 | 1 | |a Schuermans, Valerie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kemper, Charlotte |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kehrel, Coretta |e VerfasserIn |0 (DE-588)1111674345 |0 (DE-627)865850275 |0 (DE-576)476242169 |4 aut | |
| 700 | 1 | |a Funder, Anne |d 1983- |e VerfasserIn |0 (DE-588)1309356939 |0 (DE-627)1870038061 |4 aut | |
| 700 | 1 | |a Lichtenberger, Ramtin |d 1989- |e VerfasserIn |0 (DE-588)1176452606 |0 (DE-627)1047453762 |0 (DE-576)516641743 |4 aut | |
| 700 | 1 | |a Sucker, Antje |e VerfasserIn |0 (DE-588)1161138153 |0 (DE-627)1024540596 |0 (DE-576)506375412 |4 aut | |
| 700 | 1 | |a Herpel, Esther |d 1973- |e VerfasserIn |0 (DE-588)12965227X |0 (DE-627)476593662 |0 (DE-576)297767984 |4 aut | |
| 700 | 1 | |a Holland-Letz, Tim |e VerfasserIn |0 (DE-588)142336491 |0 (DE-627)658880470 |0 (DE-576)343311291 |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 700 | 1 | |a Garbe, Claus |d 1951- |e VerfasserIn |0 (DE-588)108397041 |0 (DE-627)516177893 |0 (DE-576)171143817 |4 aut | |
| 700 | 1 | |a Umansky, Viktor |d 1955- |e VerfasserIn |0 (DE-588)102885756X |0 (DE-627)731733207 |0 (DE-576)376300078 |4 aut | |
| 700 | 1 | |a Utikal, Jochen |d 1974- |e VerfasserIn |0 (DE-588)1026463750 |0 (DE-627)726765015 |0 (DE-576)371816580 |4 aut | |
| 700 | 1 | |a Gebhardt, Christoffer |d 1976- |e VerfasserIn |0 (DE-588)13051151X |0 (DE-627)503031666 |0 (DE-576)298240289 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal for ImmunoTherapy of Cancer |d London : BioMed Central, 2013 |g 7(2019,1) Artikel-Nummer 343, 10 Seiten |h Online-Ressource |w (DE-627)750086335 |w (DE-600)2719863-7 |w (DE-576)383767369 |x 2051-1426 |7 nnas |a Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies |
| 773 | 1 | 8 | |g volume:7 |g year:2019 |g number:1 |g extent:10 |a Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s40425-019-0828-1 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://jitc.bmj.com/content/7/1/343 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200514 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1026463750 |a Utikal, Jochen |m 1026463750:Utikal, Jochen |d 60000 |e 60000PU1026463750 |k 0/60000/ |p 17 | ||
| 998 | |g 102885756X |a Umansky, Viktor |m 102885756X:Umansky, Viktor |d 60000 |d 61900 |e 60000PU102885756X |e 61900PU102885756X |k 0/60000/ |k 1/60000/61900/ |p 16 | ||
| 998 | |g 1309356939 |a Funder, Anne |m 1309356939:Funder, Anne |d 60000 |e 60000PF1309356939 |k 0/60000/ |p 9 | ||
| 998 | |g 1111674345 |a Kehrel, Coretta |m 1111674345:Kehrel, Coretta |d 60000 |e 60000PK1111674345 |k 0/60000/ |p 8 | ||
| 998 | |g 1229655727 |a Gries, Mirko |m 1229655727:Gries, Mirko |d 60000 |e 60000PG1229655727 |k 0/60000/ |p 3 | ||
| 998 | |g 102885756X |a Umansky, Viktor |m 102885756X:Umansky, Viktor |d 140000 |d 60000 |d 61900 |e 140000PU102885756X |e 60000PU102885756X |e 61900PU102885756X |k 0/140000/ |k 0/60000/ |k 1/60000/61900/ |p 16 | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 14 | ||
| 998 | |g 142336491 |a Holland-Letz, Tim |m 142336491:Holland-Letz, Tim |d 50000 |e 50000PH142336491 |k 0/50000/ |p 13 | ||
| 998 | |g 12965227X |a Herpel, Esther |m 12965227X:Herpel, Esther |d 910000 |d 912000 |e 910000PH12965227X |e 912000PH12965227X |k 0/910000/ |k 1/910000/912000/ |p 12 | ||
| 999 | |a KXP-PPN1698224451 |e 3666740162 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 14.05.2020"],"recId":"1698224451","title":[{"title_sort":"Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies","title":"Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies"}],"id":{"eki":["1698224451"],"doi":["10.1186/s40425-019-0828-1"]},"origin":[{"dateIssuedDisp":"5 December 2019","dateIssuedKey":"2019"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"recId":"750086335","pubHistory":["1.2013 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"BioMed Central","dateIssuedKey":"2013","publisherPlace":"London","dateIssuedDisp":"2013-"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2019","extent":"10","issue":"1","volume":"7","text":"7(2019,1) Artikel-Nummer 343, 10 Seiten"},"disp":"Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodiesJournal for ImmunoTherapy of Cancer","note":["Gesehen am 29.06.20"],"id":{"eki":["750086335"],"zdb":["2719863-7"],"issn":["2051-1426"]},"title":[{"subtitle":"official journal of the Society for Immunotherapy of Cancer (SITC)","title":"Journal for ImmunoTherapy of Cancer","title_sort":"Journal for ImmunoTherapy of Cancer"}]}],"person":[{"roleDisplay":"VerfasserIn","family":"Wagner","given":"Nikolaus B.","display":"Wagner, Nikolaus B.","role":"aut"},{"family":"Weide","roleDisplay":"VerfasserIn","role":"aut","display":"Weide, Benjamin Matthias","given":"Benjamin Matthias"},{"display":"Gries, Mirko","role":"aut","given":"Mirko","family":"Gries","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Reith","given":"Maike","role":"aut","display":"Reith, Maike"},{"given":"Kathrin","display":"Tarnanidis, Kathrin","role":"aut","roleDisplay":"VerfasserIn","family":"Tarnanidis"},{"given":"Valerie","role":"aut","display":"Schuermans, Valerie","family":"Schuermans","roleDisplay":"VerfasserIn"},{"family":"Kemper","roleDisplay":"VerfasserIn","given":"Charlotte","display":"Kemper, Charlotte","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Kehrel","given":"Coretta","role":"aut","display":"Kehrel, Coretta"},{"family":"Funder","roleDisplay":"VerfasserIn","role":"aut","display":"Funder, Anne","given":"Anne"},{"display":"Lichtenberger, Ramtin","role":"aut","given":"Ramtin","roleDisplay":"VerfasserIn","family":"Lichtenberger"},{"given":"Antje","display":"Sucker, Antje","role":"aut","family":"Sucker","roleDisplay":"VerfasserIn"},{"display":"Herpel, Esther","role":"aut","given":"Esther","family":"Herpel","roleDisplay":"VerfasserIn"},{"given":"Tim","role":"aut","display":"Holland-Letz, Tim","family":"Holland-Letz","roleDisplay":"VerfasserIn"},{"family":"Schadendorf","roleDisplay":"VerfasserIn","given":"Dirk","role":"aut","display":"Schadendorf, Dirk"},{"family":"Garbe","roleDisplay":"VerfasserIn","role":"aut","display":"Garbe, Claus","given":"Claus"},{"given":"Viktor","role":"aut","display":"Umansky, Viktor","roleDisplay":"VerfasserIn","family":"Umansky"},{"given":"Jochen","role":"aut","display":"Utikal, Jochen","family":"Utikal","roleDisplay":"VerfasserIn"},{"given":"Christoffer","role":"aut","display":"Gebhardt, Christoffer","roleDisplay":"VerfasserIn","family":"Gebhardt"}],"name":{"displayForm":["Nikolaus B. Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis, Valerie Schuermans, Charlotte Kemper, Coretta Kehrel, Anne Funder, Ramtin Lichtenberger, Antje Sucker, Esther Herpel, Tim Holland-Letz, Dirk Schadendorf, Claus Garbe, Viktor Umansky, Jochen Utikal, and Christoffer Gebhardt"]},"physDesc":[{"extent":"10 S."}]} | ||
| SRT | |a WAGNERNIKOTUMORMICRO5201 | ||